| 1,1'-azobis(N,N-dimethylformamide) | multiple interactions | EXP | | 6480464 | Diamide inhibits the reaction [MTOR protein binds to RPTOR protein]; more ... | CTD | PMID:16183647 |
| 1,1'-azobis(N,N-dimethylformamide) | increases activity | EXP | | 6480464 | Diamide results in increased activity of MTOR protein | CTD | PMID:16183647 |
| 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine | affects phosphorylation | ISO | RGD:68534 | 6480464 | 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine affects the phosphorylation of MTOR protein | CTD | PMID:20382208 |
| 17alpha-ethynylestradiol | affects expression | ISO | RGD:68534 | 6480464 | Ethinyl Estradiol affects the expression of MTOR mRNA | CTD | PMID:17555576 |
| 17alpha-ethynylestradiol | multiple interactions | ISO | RGD:68534 | 6480464 | [Tetrachlorodibenzodioxin co-treated with Ethinyl Estradiol] results in increased expression of MTOR mRNA | CTD | PMID:17942748 |
| 17alpha-ethynylestradiol | increases expression | ISO | RGD:68534 | 6480464 | Ethinyl Estradiol results in increased expression of MTOR mRNA | CTD | PMID:17942748 |
| 17beta-estradiol | increases activity | EXP | | 6480464 | Estradiol results in increased activity of MTOR protein | CTD | PMID:16024245 |
| 17beta-estradiol | multiple interactions | EXP | | 6480464 | everolimus inhibits the reaction [Estradiol affects the activity of MTOR protein]; more ... | CTD | PMID:16033851 |
| 17beta-estradiol | affects activity | EXP | | 6480464 | Estradiol affects the activity of MTOR protein | CTD | PMID:16033851 |
| 2,3,7,8-tetrachlorodibenzodioxine | multiple interactions | ISO | RGD:68534 | 6480464 | [Tetrachlorodibenzodioxin co-treated with Ethinyl Estradiol] results in increased expression of MTOR mRNA | CTD | PMID:17942748 |
| 2,3,7,8-tetrachlorodibenzodioxine | multiple interactions | EXP | | 6480464 | alpha-naphthoflavone inhibits the reaction [Tetrachlorodibenzodioxin results in decreased phosphorylation of MTOR protein]; more ... | CTD | PMID:22266097 |
| 2,3,7,8-tetrachlorodibenzodioxine | decreases phosphorylation | EXP | | 6480464 | Tetrachlorodibenzodioxin results in decreased phosphorylation of MTOR protein | CTD | PMID:22266097 |
| 2,4-dinitrotoluene | affects expression | ISO | RGD:68371 | 6480464 | 2,4-dinitrotoluene affects the expression of MTOR mRNA | CTD | PMID:21346803 |
| 2,6-dinitrotoluene | affects expression | ISO | RGD:68371 | 6480464 | 2,6-dinitrotoluene affects the expression of MTOR mRNA | CTD | PMID:21346803 |
| 3-methyladenine | multiple interactions | EXP | | 6480464 | 3-methyladenine inhibits the reaction [MAP3K5 protein results in decreased phosphorylation of MTOR protein] | CTD | PMID:20929985 |
| 4-hydroxynon-2-enal | decreases expression | EXP | | 6480464 | 4-hydroxy-2-nonenal results in decreased expression of MTOR mRNA | CTD | PMID:12419474 |
| 5,6alpha-epoxy-5alpha-cholestan-3beta-ol | increases phosphorylation | ISO | RGD:68371 | 6480464 | cholesterol alpha-oxide results in increased phosphorylation of MTOR protein | CTD | PMID:20466046 |
| 5,6alpha-epoxy-5alpha-cholestan-3beta-ol | multiple interactions | ISO | RGD:68371 | 6480464 | tyrphostin AG 1478 inhibits the reaction [cholesterol alpha-oxide results in increased phosphorylation of MTOR protein] | CTD | PMID:20466046 |
| 5-amino-1-(5-phospho-D-ribosyl)imidazole-4-carboxamide | decreases activity | EXP | | 6480464 | AICA ribonucleotide results in decreased activity of MTOR protein | CTD | PMID:19625624 |
| 5-amino-1-(5-phospho-D-ribosyl)imidazole-4-carboxamide | multiple interactions | ISO | RGD:68534 | 6480464 | AICA ribonucleotide promotes the reaction [Cadmium results in decreased phosphorylation of MTOR protein] | CTD | PMID:21767558 |
| 7,12-dimethyltetraphene | decreases expression | ISO | RGD:68534 | 6480464 | 9,10-Dimethyl-1,2-benzanthracene results in decreased expression of MTOR protein modified form | CTD | PMID:21785161 |
| 7,12-dimethyltetraphene | increases expression | ISO | RGD:68534 | 6480464 | 9,10-Dimethyl-1,2-benzanthracene results in increased expression of MTOR protein modified form | CTD | PMID:21785161 |
| 7-ketocholesterol | increases phosphorylation | ISO | RGD:68371 | 6480464 | 7-ketocholesterol results in increased phosphorylation of MTOR protein | CTD | PMID:20466046 |
| 7-ketocholesterol | multiple interactions | ISO | RGD:68371 | 6480464 | tyrphostin AG 1478 inhibits the reaction [7-ketocholesterol results in increased phosphorylation of MTOR protein] | CTD | PMID:20466046 |
| 9-cis-retinoic acid | multiple interactions | ISO | RGD:68534 | 6480464 | [15-deoxy-delta(12,14)-prostaglandin J2 co-treated with alitretinoin] results in decreased phosphorylation of MTOR protein | CTD | PMID:16611854 |
| acetaldehyde | decreases phosphorylation | EXP | | 6480464 | Acetaldehyde results in decreased phosphorylation of MTOR protein | CTD | PMID:16962100 |
| afimoxifene | decreases response to substance | EXP | | 6480464 | MTOR results in decreased susceptibility to 4-hydroxytamoxifen | CTD | PMID:19016759 |
| afimoxifene | multiple interactions | EXP | | 6480464 | [Sirolimus results in decreased activity of MTOR protein] which results in increased susceptibility to 4-hydroxytamoxifen | CTD | PMID:19016759 |
| amiodarone | multiple interactions | EXP | | 6480464 | Amiodarone inhibits the reaction [MTOR protein results in increased phosphorylation of EIF4EBP1 protein] | CTD | PMID:19771169 |
| ammonium chloride | affects expression | ISO | RGD:68371 | 6480464 | Ammonium Chloride affects the expression of MTOR mRNA | CTD | PMID:16483693 |
| androst-4-ene-3,17-dione | multiple interactions | EXP | | 6480464 | everolimus inhibits the reaction [Androstenedione affects the activity of MTOR protein]; more ... | CTD | PMID:16033851 |
| androst-4-ene-3,17-dione | affects activity | EXP | | 6480464 | Androstenedione affects the activity of MTOR protein | CTD | PMID:16033851 |
| benzo[a]pyrene | multiple interactions | ISO | RGD:68534 | 6480464 | [Benzo(a)pyrene co-treated with XPA gene mutant form co-treated with TRP53 gene mutant form] results in decreased expression of MTOR mRNA | CTD | PMID:21715664 |
| benzo[a]pyrene | multiple interactions | ISO | RGD:68534 | 6480464 | AHR protein affects the reaction [Benzo(a)pyrene affects the expression of MTOR mRNA] | CTD | PMID:22228805 |
| butan-1-ol | affects activity | ISO | RGD:68534 | 6480464 | 1-Butanol affects the activity of MTOR protein | CTD | PMID:16537399 |
| cadmium atom | multiple interactions | ISO | RGD:68534 | 6480464 | AICA ribonucleotide promotes the reaction [Cadmium results in decreased phosphorylation of MTOR protein]; more ... | CTD | PMID:21767558 |
| cadmium dichloride | increases phosphorylation | EXP | | 6480464 | Cadmium Chloride results in increased phosphorylation of MTOR protein | CTD | PMID:18021293 |
| cadmium dichloride | increases phosphorylation | ISO | RGD:68371 | 6480464 | Cadmium Chloride results in increased phosphorylation of MTOR protein | CTD | PMID:18021293 more ... |
| cadmium dichloride | increases phosphorylation | ISO | RGD:68371 | 6480464 | Cadmium Chloride results in increased phosphorylation of MTOR protein | CTD | PMID:21195169 more ... |
| cadmium dichloride | increases phosphorylation | ISO | RGD:68371 | 6480464 | Cadmium Chloride results in increased phosphorylation of MTOR protein | CTD | PMID:21544200 more ... |
| cadmium dichloride | multiple interactions | ISO | RGD:68371 | 6480464 | 1,2-bis(2-aminophenoxy)ethane N,N,N',N'-tetraacetic acid acetoxymethyl ester inhibits the reaction [Cadmium Chloride results in increased phosphorylation of MTOR protein]; more ... | CTD | PMID:21544200 |
| cadmium dichloride | multiple interactions | ISO | RGD:68371 | 6480464 | Acetylcysteine inhibits the reaction [Cadmium Chloride results in increased phosphorylation of MTOR protein] | CTD | PMID:21195169 |
| cadmium dichloride | increases phosphorylation | ISO | RGD:68534 | 6480464 | Cadmium Chloride results in increased phosphorylation of MTOR protein | CTD | PMID:21544200 |
| cadmium dichloride | multiple interactions | ISO | RGD:68534 | 6480464 | 1,2-bis(2-aminophenoxy)ethane N,N,N',N'-tetraacetic acid acetoxymethyl ester inhibits the reaction [Cadmium Chloride results in increased phosphorylation of MTOR protein]; more ... | CTD | PMID:21544200 |
| caffeine | decreases activity | EXP | | 6480464 | Caffeine results in decreased activity of MTOR protein | CTD | PMID:21081844 |
| calciol | decreases expression | EXP | | 6480464 | Cholecalciferol results in decreased expression of MTOR | CTD | PMID:18628207 |
| calciol | decreases response to substance | EXP | | 6480464 | MTOR results in decreased susceptibility to Cholecalciferol | CTD | PMID:18628207 |
| calciol | multiple interactions | EXP | | 6480464 | MTOR mutant form promotes the reaction [Cholecalciferol results in increased expression of BECN1 protein] | CTD | PMID:18628207 |
| calcium atom | multiple interactions | ISO | RGD:68371 | 6480464 | Calcium affects the reaction [[Phenylephrine results in increased activity of ADRA1A protein] which results in increased phosphorylation of MTOR protein] | CTD | PMID:12935885 |
| calcium(0) | multiple interactions | ISO | RGD:68371 | 6480464 | Calcium affects the reaction [[Phenylephrine results in increased activity of ADRA1A protein] which results in increased phosphorylation of MTOR protein] | CTD | PMID:12935885 |
| capsaicin | decreases phosphorylation | EXP | | 6480464 | Capsaicin results in decreased phosphorylation of MTOR protein | CTD | PMID:22226932 |
| capsaicin | increases phosphorylation | EXP | | 6480464 | Capsaicin results in increased phosphorylation of MTOR protein | CTD | PMID:19139269 |
| capsaicin | multiple interactions | EXP | | 6480464 | 2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one inhibits the reaction [Capsaicin results in increased phosphorylation of MTOR protein]; more ... | CTD | PMID:19139269 |
| cisplatin | multiple interactions | EXP | | 6480464 | Cisplatin promotes the reaction [temsirolimus inhibits the reaction [MTOR protein results in increased phosphorylation of EIF4EBP1 protein]]; more ... | CTD | PMID:21358348 |
| cisplatin | multiple interactions | EXP | | 6480464 | Topotecan inhibits the reaction [Cisplatin results in increased phosphorylation of MTOR protein] | CTD | PMID:20935474 |
| cisplatin | decreases phosphorylation | EXP | | 6480464 | Cisplatin results in decreased phosphorylation of MTOR protein | CTD | PMID:18058806 |
| cisplatin | multiple interactions | EXP | | 6480464 | Sirolimus promotes the reaction [Cisplatin results in decreased phosphorylation of MTOR protein] | CTD | PMID:18058806 |
| cisplatin | multiple interactions | EXP | | 6480464 | [Cisplatin results in increased phosphorylation of TP63 protein alternative form] which results in decreased expression of MTOR protein | CTD | PMID:21191146 |
| cisplatin | increases phosphorylation | EXP | | 6480464 | Cisplatin results in increased phosphorylation of MTOR protein | CTD | PMID:20935474 |
| clofibrate | multiple interactions | ISO | RGD:68534 | 6480464 | [Clofibrate co-treated with Acetaminophen] affects the expression of MTOR mRNA; more ... | CTD | PMID:17585979 |
| clofibrate | decreases phosphorylation | ISO | RGD:68371 | 6480464 | Clofibrate results in decreased phosphorylation of MTOR protein | CTD | PMID:16616211 |
| corticosterone | decreases phosphorylation | ISO | RGD:68534 | 6480464 | Corticosterone results in decreased phosphorylation of MTOR protein | CTD | PMID:21647420 |
| curcumin | decreases phosphorylation | EXP | | 6480464 | Curcumin results in decreased phosphorylation of MTOR protein | CTD | PMID:21450334 |
| D-glucose | increases activity | ISO | RGD:68534 | 6480464 | Glucose results in increased activity of MTOR protein | CTD | PMID:19765649 |
| D-glucose | multiple interactions | ISO | RGD:68534 | 6480464 | resveratrol inhibits the reaction [Glucose results in increased activity of MTOR protein] | CTD | PMID:19765649 |
| dasatinib (anhydrous) | decreases phosphorylation | EXP | | 6480464 | dasatinib results in decreased phosphorylation of MTOR protein | CTD | PMID:20629079 |
| daunorubicin | increases phosphorylation | EXP | | 6480464 | Daunorubicin results in increased phosphorylation of MTOR protein | CTD | PMID:21898527 |
| daunorubicin | multiple interactions | EXP | | 6480464 | Sirolimus inhibits the reaction [Daunorubicin results in increased phosphorylation of MTOR protein] | CTD | PMID:21898527 |
| diarsenic trioxide | decreases phosphorylation | EXP | | 6480464 | arsenic trioxide results in decreased phosphorylation of MTOR protein | CTD | PMID:21594580 |
| dimercaprol | multiple interactions | EXP | | 6480464 | Dimercaprol inhibits the reaction [oxophenylarsine inhibits the reaction [MTOR protein binds to RPTOR protein]] | CTD | PMID:16183647 |
| dioxygen | multiple interactions | EXP | | 6480464 | Sirolimus inhibits the reaction [Oxygen deficiency results in increased expression of MTOR mRNA]; more ... | CTD | PMID:17968710 |
| dioxygen | increases phosphorylation | EXP | | 6480464 | Oxygen results in increased phosphorylation of MTOR protein | CTD | PMID:19587783 |
| dioxygen | increases expression | EXP | | 6480464 | Oxygen deficiency results in increased expression of MTOR mRNA | CTD | PMID:17968710 |
| dopamine | decreases phosphorylation | EXP | | 6480464 | Dopamine results in decreased phosphorylation of MTOR protein | CTD | PMID:19410601 |
| doxorubicin | multiple interactions | ISO | RGD:68534 | 6480464 | Doxorubicin results in decreased activity of and results in decreased phosphorylation of MTOR protein | CTD | PMID:19103993 |
| doxorubicin | multiple interactions | ISO | RGD:68371 | 6480464 | MTOR protein promotes the reaction [NRG1 protein inhibits the reaction [Doxorubicin results in decreased expression of TNNI3 protein]]; more ... | CTD | PMID:19801490 |
| doxorubicin | decreases phosphorylation | ISO | RGD:68371 | 6480464 | Doxorubicin results in decreased phosphorylation of MTOR protein | CTD | PMID:19801490 |
| doxorubicin | decreases response to substance | ISO | RGD:68534 | 6480464 | MTOR protein results in decreased susceptibility to Doxorubicin | CTD | PMID:19103993 |
| ethanol | multiple interactions | ISO | RGD:68371 | 6480464 | Ethanol inhibits the reaction [[Phenylephrine results in increased activity of ADRA1A protein] which results in increased phosphorylation of MTOR protein] | CTD | PMID:12935885 |
| ethylene glycol bis(2-aminoethyl)tetraacetic acid | multiple interactions | ISO | RGD:68371 | 6480464 | Egtazic Acid inhibits the reaction [Cadmium Chloride results in increased phosphorylation of MTOR protein] | CTD | PMID:21544200 |
| ethylene glycol bis(2-aminoethyl)tetraacetic acid | multiple interactions | ISO | RGD:68534 | 6480464 | Egtazic Acid inhibits the reaction [Cadmium Chloride results in increased phosphorylation of MTOR protein] | CTD | PMID:21544200 |
| everolimus | decreases activity | EXP | | 6480464 | everolimus results in decreased activity of MTOR protein | CTD | PMID:16033851 PMID:20890178 |
| everolimus | multiple interactions | EXP | | 6480464 | everolimus inhibits the reaction [Estradiol affects the activity of MTOR protein]; more ... | CTD | PMID:16033851 |
| everolimus | multiple interactions | EXP | | 6480464 | everolimus inhibits the reaction [MTOR results in decreased susceptibility to trabectedin] | CTD | PMID:21622721 |
| everolimus | decreases activity | EXP | | 6480464 | everolimus results in decreased activity of MTOR | CTD | PMID:21622721 |
| fluoxetine | multiple interactions | ISO | RGD:68371 | 6480464 | [Fluoxetine co-treated with Methylphenidate] results in increased phosphorylation of MTOR protein; more ... | CTD | PMID:21753012 |
| fulvestrant | decreases response to substance | EXP | | 6480464 | MTOR results in decreased susceptibility to fulvestrant | CTD | PMID:19016759 |
| fulvestrant | multiple interactions | EXP | | 6480464 | [Sirolimus results in decreased activity of MTOR protein] which results in increased susceptibility to fulvestrant | CTD | PMID:19016759 |
| gefitinib | decreases phosphorylation | EXP | | 6480464 | gefitinib results in decreased phosphorylation of MTOR protein | CTD | PMID:21655094 |
| glucose | increases activity | ISO | RGD:68534 | 6480464 | Glucose results in increased activity of MTOR protein | CTD | PMID:19765649 |
| glucose | multiple interactions | ISO | RGD:68534 | 6480464 | resveratrol inhibits the reaction [Glucose results in increased activity of MTOR protein] | CTD | PMID:19765649 |
| hexachlorobenzene | decreases expression | ISO | RGD:68371 | 6480464 | Hexachlorobenzene results in decreased expression of MTOR mRNA | CTD | PMID:15159207 |
| imatinib | multiple interactions | EXP | | 6480464 | imatinib promotes the reaction [NVP ADW742 inhibits the reaction [IGF1 protein results in increased phosphorylation of MTOR protein]] | CTD | PMID:16740780 |
| imatinib | multiple interactions | EXP | | 6480464 | tetraarsenic tetrasulfide promotes the reaction [imatinib results in decreased expression of MTOR protein] | CTD | PMID:19208803 |
| imatinib | decreases expression | EXP | | 6480464 | imatinib results in decreased expression of MTOR protein | CTD | PMID:19208803 |
| letrozole | multiple interactions | EXP | | 6480464 | [letrozole co-treated with everolimus] inhibits the reaction [Androstenedione affects the activity of MTOR protein]; more ... | CTD | PMID:16033851 |
| lithium atom | multiple interactions | ISO | RGD:68534 | 6480464 | [Lithium results in decreased activity of GSK3B protein] which results in increased activity of MTOR protein | CTD | PMID:17921520 |
| LY294002 | multiple interactions | EXP | | 6480464 | 2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one inhibits the reaction [Capsaicin results in increased phosphorylation of MTOR protein] | CTD | PMID:19139269 |
| LY294002 | decreases phosphorylation | EXP | | 6480464 | 2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one results in decreased phosphorylation of MTOR protein | CTD | PMID:17148679 |
| lysophosphatidic acid | increases phosphorylation | ISO | RGD:68371 | 6480464 | lysophosphatidic acid results in increased phosphorylation of MTOR protein | CTD | PMID:14769825 |
| maneb | multiple interactions | ISO | RGD:68534 | 6480464 | Maneb promotes the reaction [Paraquat results in increased expression of MTOR protein]; more ... | CTD | PMID:22292029 |
| maneb | increases expression | ISO | RGD:68534 | 6480464 | Maneb results in increased expression of MTOR protein | CTD | PMID:22292029 |
| manganese atom | decreases phosphorylation | EXP | | 6480464 | Manganese results in decreased phosphorylation of MTOR protein | CTD | PMID:17043766 |
| manganese atom | increases phosphorylation | EXP | | 6480464 | Manganese results in increased phosphorylation of MTOR protein | CTD | PMID:17043766 |
| manganese(0) | decreases phosphorylation | EXP | | 6480464 | Manganese results in decreased phosphorylation of MTOR protein | CTD | PMID:17043766 |
| manganese(0) | increases phosphorylation | EXP | | 6480464 | Manganese results in increased phosphorylation of MTOR protein | CTD | PMID:17043766 |
| melatonin | multiple interactions | EXP | | 6480464 | Melatonin promotes the reaction [MTOR protein results in increased phosphorylation of EIF4EBP1 protein] | CTD | PMID:19054297 |
| melatonin | increases activity | EXP | | 6480464 | Melatonin results in increased activity of MTOR protein | CTD | PMID:19054297 |
| methamphetamine | multiple interactions | EXP | | 6480464 | Methamphetamine inhibits the reaction [MTOR protein results in increased phosphorylation of EIF4EBP1 protein] | CTD | PMID:19054297 |
| methamphetamine | multiple interactions | ISO | RGD:68371 | 6480464 | Taurine inhibits the reaction [Methamphetamine results in decreased phosphorylation of MTOR protein] | CTD | PMID:23041169 |
| methamphetamine | decreases phosphorylation | ISO | RGD:68371 | 6480464 | Methamphetamine results in decreased phosphorylation of MTOR protein | CTD | PMID:23041169 |
| methamphetamine | decreases phosphorylation | EXP | | 6480464 | Methamphetamine results in decreased phosphorylation of MTOR protein | CTD | PMID:19054297 |
| methylphenidate | multiple interactions | ISO | RGD:68371 | 6480464 | [Fluoxetine co-treated with Methylphenidate] results in increased phosphorylation of MTOR protein; more ... | CTD | PMID:21753012 |
| methylphenidate | affects expression | ISO | RGD:68371 | 6480464 | Methylphenidate affects the expression of MTOR mRNA | CTD | PMID:21753012 |
| mifepristone | multiple interactions | EXP | | 6480464 | Mifepristone inhibits the reaction [Tetrachlorodibenzodioxin results in decreased phosphorylation of MTOR protein] | CTD | PMID:22266097 |
| N-acetyl-L-cysteine | multiple interactions | ISO | RGD:68371 | 6480464 | Acetylcysteine inhibits the reaction [Cadmium Chloride results in increased phosphorylation of MTOR protein] | CTD | PMID:21195169 |
| N-ethyl-N-nitrosourea | increases mutagenesis | ISO | RGD:68534 | 6480464 | Ethylnitrosourea results in increased mutagenesis of MTOR gene | CTD | PMID:16724327 PMID:15485918 |
| N-ethyl-N-nitrosourea | increases mutagenesis | ISO | RGD:68534 | 6480464 | Ethylnitrosourea results in increased mutagenesis of MTOR gene | CTD | PMID:15485918 PMID:16724327 |
| nicotinamide | increases phosphorylation | EXP | | 6480464 | Niacinamide results in increased phosphorylation of MTOR protein | CTD | PMID:19928762 |
| nicotinamide | multiple interactions | EXP | | 6480464 | Niacinamide inhibits the reaction [resveratrol results in decreased phosphorylation of MTOR protein] | CTD | PMID:19928762 |
| nicotinic acid | multiple interactions | ISO | RGD:68371 | 6480464 | Niacin results in decreased phosphorylation of and results in decreased activity of MTOR protein | CTD | PMID:12837665 |
| nitric oxide | multiple interactions | ISO | RGD:68534 | 6480464 | [Sirolimus results in decreased activity of MTOR protein] inhibits the reaction [resveratrol inhibits the reaction [Lipopolysaccharides results in increased abundance of Nitric Oxide]] | CTD | PMID:22363816 |
| oxaliplatin | increases phosphorylation | EXP | | 6480464 | oxaliplatin results in increased phosphorylation of MTOR protein | CTD | PMID:19147571 |
| paracetamol | multiple interactions | ISO | RGD:68534 | 6480464 | PPARA affects the reaction [[Clofibrate co-treated with Acetaminophen] affects the expression of MTOR mRNA] | CTD | PMID:17585979 |
| paraquat | decreases phosphorylation | EXP | | 6480464 | Paraquat results in decreased phosphorylation of MTOR protein | CTD | PMID:17341480 PMID:20929985 |
| paraquat | increases expression | ISO | RGD:68534 | 6480464 | Paraquat results in increased expression of MTOR protein | CTD | PMID:22292029 |
| paraquat | decreases expression | ISO | RGD:68534 | 6480464 | Paraquat results in decreased expression of MTOR mRNA | CTD | PMID:21371552 |
| paraquat | multiple interactions | ISO | RGD:68534 | 6480464 | Maneb promotes the reaction [Paraquat results in increased expression of MTOR protein]; more ... | CTD | PMID:22292029 |
| paraquat | decreases phosphorylation | EXP | | 6480464 | Paraquat results in decreased phosphorylation of MTOR protein | CTD | PMID:20929985 PMID:17341480 |
| perhexiline | multiple interactions | EXP | | 6480464 | Perhexiline inhibits the reaction [MTOR protein results in increased phosphorylation of EIF4EBP1 protein] | CTD | PMID:19771169 |
| phenylephrine | multiple interactions | ISO | RGD:68371 | 6480464 | Ethanol inhibits the reaction [[Phenylephrine results in increased activity of ADRA1A protein] which results in increased phosphorylation of MTOR protein]; more ... | CTD | PMID:12935885 |
| pirinixic acid | increases expression | ISO | RGD:68534 | 6480464 | pirinixic acid results in increased expression of MTOR mRNA | CTD | PMID:18301758 |
| pravastatin | increases phosphorylation | EXP | | 6480464 | Pravastatin results in increased phosphorylation of MTOR protein | CTD | PMID:15625077 |
| prostaglandin E2 | multiple interactions | ISO | RGD:68534 | 6480464 | [Sirolimus results in decreased activity of MTOR protein] inhibits the reaction [resveratrol inhibits the reaction [Lipopolysaccharides results in increased abundance of Dinoprostone]] | CTD | PMID:22363816 |
| resveratrol | affects expression | EXP | | 6480464 | resveratrol affects the expression of MTOR mRNA | CTD | PMID:18586690 |
| resveratrol | multiple interactions | EXP | | 6480464 | Niacinamide inhibits the reaction [resveratrol results in decreased phosphorylation of MTOR protein]; more ... | CTD | PMID:19928762 |
| resveratrol | multiple interactions | ISO | RGD:68534 | 6480464 | [Sirolimus results in decreased activity of MTOR protein] inhibits the reaction [resveratrol affects the susceptibility to Lipopolysaccharides]; more ... | CTD | PMID:22363816 |
| resveratrol | multiple interactions | ISO | RGD:68534 | 6480464 | [resveratrol results in decreased activity of MTOR protein] inhibits the reaction [Tunicamycin results in increased expression of DDIT3 mRNA]; more ... | CTD | PMID:21321189 |
| resveratrol | multiple interactions | ISO | RGD:68534 | 6480464 | resveratrol promotes the reaction [MTOR protein binds to DEPTOR protein] | CTD | PMID:20851890 |
| resveratrol | multiple interactions | ISO | RGD:68534 | 6480464 | resveratrol inhibits the reaction [Glucose results in increased activity of MTOR protein] | CTD | PMID:19765649 |
| resveratrol | multiple interactions | EXP | | 6480464 | [resveratrol results in increased activity of SIRT1 protein] which results in decreased activity of MTOR protein; more ... | CTD | PMID:20169165 |
| resveratrol | decreases phosphorylation | EXP | | 6480464 | resveratrol results in decreased phosphorylation of MTOR protein | CTD | PMID:21168265 PMID:21179458 |
| resveratrol | decreases expression | EXP | | 6480464 | resveratrol results in decreased expression of MTOR protein modified form | CTD | PMID:22234583 |
| resveratrol | multiple interactions | EXP | | 6480464 | [resveratrol results in decreased activity of MTOR protein] which results in decreased expression of PKM mRNA; more ... | CTD | PMID:22574221 |
| resveratrol | multiple interactions | EXP | | 6480464 | [resveratrol results in decreased activity of MTOR protein] which results in decreased expression of DDIT3 protein | CTD | PMID:21321189 |
| resveratrol | decreases activity | EXP | | 6480464 | resveratrol results in decreased activity of MTOR protein | CTD | PMID:21321189 PMID:22574221 |
| resveratrol | multiple interactions | EXP | | 6480464 | PTEN protein promotes the reaction [resveratrol results in decreased phosphorylation of MTOR protein] | CTD | PMID:21168265 |
| resveratrol | increases phosphorylation | ISO | RGD:68534 | 6480464 | resveratrol results in increased phosphorylation of MTOR protein | CTD | PMID:22363816 |
| resveratrol | decreases phosphorylation | ISO | RGD:68534 | 6480464 | resveratrol results in decreased phosphorylation of MTOR protein | CTD | PMID:20851890 |
| resveratrol | increases expression | EXP | | 6480464 | resveratrol results in increased expression of MTOR mRNA | CTD | PMID:12002526 |
| resveratrol | multiple interactions | ISO | RGD:68534 | 6480464 | resveratrol inhibits the reaction [TNF protein results in increased phosphorylation of MTOR protein] | CTD | PMID:22069489 |
| rosiglitazone | increases phosphorylation | ISO | RGD:68371 | 6480464 | rosiglitazone results in increased phosphorylation of MTOR protein | CTD | PMID:19397913 |
| simvastatin | decreases phosphorylation | ISO | RGD:68534 | 6480464 | Simvastatin results in decreased phosphorylation of MTOR protein | CTD | PMID:22144680 |
| sirolimus | multiple interactions | EXP | | 6480464 | [Oxygen deficiency co-treated with Sirolimus] results in decreased expression of MTOR protein; more ... | CTD | PMID:17968710 |
| sirolimus | decreases activity | ISO | RGD:68534 | 6480464 | Sirolimus results in decreased activity of MTOR protein | CTD | PMID:19567381 more ... |
| sirolimus | decreases phosphorylation | EXP | | 6480464 | Sirolimus results in decreased phosphorylation of MTOR protein | CTD | PMID:19125612 more ... |
| sirolimus | multiple interactions | EXP | | 6480464 | [Sirolimus results in decreased activity of MTOR protein] which results in decreased phosphorylation of RPS6 protein | CTD | PMID:17908691 PMID:20169165 |
| sirolimus | multiple interactions | EXP | | 6480464 | [Sirolimus results in decreased activity of MTOR protein] which results in decreased phosphorylation of RPS6KB1 protein | CTD | PMID:20169165 PMID:22574221 |
| sirolimus | multiple interactions | EXP | | 6480464 | [Sirolimus results in decreased activity of MTOR protein] which results in decreased phosphorylation of EIF4EBP1 protein | CTD | PMID:14673156 PMID:20169165 |
| sirolimus | multiple interactions | EXP | | 6480464 | [Sirolimus results in decreased activity of MTOR protein] which results in decreased expression of PKM protein | CTD | PMID:22574221 |
| sirolimus | multiple interactions | EXP | | 6480464 | [Sirolimus results in decreased activity of MTOR protein] which results in decreased expression of DDIT3 protein | CTD | PMID:21321189 |
| sirolimus | decreases activity | EXP | | 6480464 | Sirolimus results in decreased activity of MTOR protein | CTD | PMID:11602639 more ... |
| sirolimus | multiple interactions | ISO | RGD:68534 | 6480464 | [Sirolimus results in decreased activity of MTOR protein] inhibits the reaction [resveratrol affects the susceptibility to Lipopolysaccharides]; more ... | CTD | PMID:22363816 |
| sirolimus | multiple interactions | ISO | RGD:68534 | 6480464 | Sirolimus inhibits the reaction [TNF protein results in increased phosphorylation of MTOR protein] | CTD | PMID:22069489 |
| sirolimus | decreases activity | EXP | | 6480464 | Sirolimus results in decreased activity of MTOR protein | CTD | PMID:11602639 more ... |
| sirolimus | decreases phosphorylation | EXP | | 6480464 | Sirolimus results in decreased phosphorylation of MTOR protein | CTD | PMID:19125612 more ... |
| sirolimus | decreases activity | EXP | | 6480464 | Sirolimus results in decreased activity of MTOR protein | CTD | PMID:18381446 more ... |
| sirolimus | decreases phosphorylation | EXP | | 6480464 | Sirolimus results in decreased phosphorylation of MTOR protein | CTD | PMID:19815708 more ... |
| sirolimus | decreases phosphorylation | EXP | | 6480464 | Sirolimus results in decreased phosphorylation of MTOR protein | CTD | PMID:19815708 more ... |
| sirolimus | decreases activity | EXP | | 6480464 | Sirolimus results in decreased activity of MTOR protein | CTD | PMID:18381446 more ... |
| sirolimus | decreases phosphorylation | EXP | | 6480464 | Sirolimus results in decreased phosphorylation of MTOR protein | CTD | PMID:21450334 more ... |
| sirolimus | decreases activity | EXP | | 6480464 | Sirolimus results in decreased activity of MTOR protein | CTD | PMID:11602639 more ... |
| sirolimus | decreases phosphorylation | EXP | | 6480464 | Sirolimus results in decreased phosphorylation of MTOR protein | CTD | PMID:20682991 more ... |
| sirolimus | decreases activity | ISO | RGD:68534 | 6480464 | Sirolimus results in decreased activity of MTOR protein | CTD | PMID:20368307 PMID:19567381 |
| sirolimus | decreases phosphorylation | EXP | | 6480464 | Sirolimus results in decreased phosphorylation of MTOR protein | CTD | PMID:20682991 more ... |
| sirolimus | decreases activity | EXP | | 6480464 | Sirolimus results in decreased activity of MTOR protein | CTD | PMID:18381446 more ... |
| sirolimus | multiple interactions | EXP | | 6480464 | [Sirolimus inhibits the reaction [MTOR protein binds to RPTOR protein]] which results in increased expression of MAP1LC3A protein alternative form | CTD | PMID:21742779 |
| sirolimus | decreases phosphorylation | ISO | RGD:68371 | 6480464 | Sirolimus results in decreased phosphorylation of MTOR protein | CTD | PMID:18640276 |
| sirolimus | increases activity | ISO | RGD:68534 | 6480464 | Sirolimus results in increased activity of MTOR protein | CTD | PMID:19151764 |
| sirolimus | decreases phosphorylation | ISO | RGD:68534 | 6480464 | Sirolimus results in decreased phosphorylation of MTOR protein | CTD | PMID:18640276 |
| sirolimus | multiple interactions | ISO | RGD:68534 | 6480464 | Sirolimus inhibits the reaction [MTOR protein results in increased phosphorylation of RPS6KB1 protein] | CTD | PMID:19567381 |
| sirolimus | decreases activity | ISO | RGD:68534 | 6480464 | Sirolimus results in decreased activity of MTOR protein | CTD | PMID:19567381 PMID:20368307 |
| sirolimus | increases activity | EXP | | 6480464 | Sirolimus results in increased activity of MTOR protein | CTD | PMID:19151764 |
| sirolimus | multiple interactions | EXP | | 6480464 | [Sirolimus results in decreased phosphorylation of MTOR protein] which results in decreased chemical synthesis of Reactive Oxygen Species | CTD | PMID:20680277 |
| sirolimus | decreases phosphorylation | EXP | | 6480464 | Sirolimus results in decreased phosphorylation of MTOR protein | CTD | PMID:21450334 more ... |
| sirolimus | decreases expression | EXP | | 6480464 | Sirolimus results in decreased expression of MTOR mRNA | CTD | PMID:19698219 |
| sirolimus | multiple interactions | EXP | | 6480464 | [Sirolimus results in decreased activity of MTOR protein] which results in increased susceptibility to 4-hydroxytamoxifen; more ... | CTD | PMID:19016759 |
| sirolimus | multiple interactions | EXP | | 6480464 | [Sirolimus results in decreased activity of MTOR protein] which results in decreased phosphorylation of TP53 protein | CTD | PMID:11602639 |
| sirolimus | multiple interactions | EXP | | 6480464 | [Sirolimus results in decreased activity of MTOR protein] which results in decreased phosphorylation of RPS6 protein; more ... | CTD | PMID:17908691 |
| sirolimus | multiple interactions | EXP | | 6480464 | [Sirolimus results in decreased activity of MTOR protein] which results in decreased phosphorylation of EIF4EBP1 protein | CTD | PMID:14673156 |
| sirolimus | decreases activity | EXP | | 6480464 | [Sirolimus results in decreased activity of MTOR protein] which results in decreased activity of RPS6KB1 protein | CTD | PMID:14673156 |
| sirolimus | multiple interactions | EXP | | 6480464 | [Sirolimus results in decreased activity of MTOR protein] inhibits the reaction [PDGFB protein results in increased phosphorylation of and results in increased activity of RPS6KB1 protein] | CTD | PMID:15919668 |
| sirolimus | multiple interactions | EXP | | 6480464 | Sirolimus results in decreased activity of [MTOR protein binds to RPTOR protein]; more ... | CTD | PMID:18776922 |
| sirolimus | multiple interactions | EXP | | 6480464 | Sirolimus results in decreased activity of [MTOR protein binds to RPTOR protein binds to MLST8 protein] | CTD | PMID:19505958 |
| sirolimus | decreases activity | EXP | | 6480464 | Sirolimus results in decreased activity of MTOR protein | CTD | PMID:15782132 more ... |
| sirolimus | decreases activity | EXP | | 6480464 | Sirolimus results in decreased activity of MTOR mRNA | CTD | PMID:17996122 |
| sirolimus | multiple interactions | EXP | | 6480464 | Sirolimus promotes the reaction [Cisplatin results in decreased phosphorylation of MTOR protein] | CTD | PMID:18058806 |
| sirolimus | multiple interactions | EXP | | 6480464 | Sirolimus inhibits the reaction [EGF protein results in increased phosphorylation of MTOR protein] | CTD | PMID:21187475 |
| sirolimus | multiple interactions | EXP | | 6480464 | Sirolimus inhibits the reaction [Daunorubicin results in increased phosphorylation of MTOR protein] | CTD | PMID:21898527 |
| sirolimus | multiple interactions | EXP | | 6480464 | [Sirolimus co-treated with Photosensitizing Agents] affects the phosphorylation of MTOR protein | CTD | PMID:19125612 |
| sirolimus | multiple interactions | EXP | | 6480464 | MTOR protein inhibits the reaction [Sirolimus results in decreased activity of RPS6KB2 protein] | CTD | PMID:12087098 |
| tamoxifen | decreases activity | EXP | | 6480464 | Tamoxifen results in decreased activity of MTOR protein | CTD | PMID:19931998 |
| tamoxifen | affects expression | ISO | RGD:68534 | 6480464 | Tamoxifen affects the expression of MTOR mRNA | CTD | PMID:17555576 |
| tamoxifen | multiple interactions | EXP | | 6480464 | [Tamoxifen results in decreased activity of MTOR protein] which results in decreased phosphorylation of RPS6KB1 protein | CTD | PMID:19931998 |
| taurine | multiple interactions | ISO | RGD:68371 | 6480464 | Taurine inhibits the reaction [Methamphetamine results in decreased phosphorylation of MTOR protein] | CTD | PMID:23041169 |
| topotecan | multiple interactions | EXP | | 6480464 | Topotecan inhibits the reaction [Cisplatin results in increased phosphorylation of MTOR protein] | CTD | PMID:20935474 |
| trans-resveratrol | affects expression | EXP | | 6480464 | resveratrol affects the expression of MTOR mRNA | CTD | PMID:18586690 |
| trans-resveratrol | multiple interactions | ISO | RGD:68534 | 6480464 | [Sirolimus results in decreased activity of MTOR protein] inhibits the reaction [resveratrol affects the susceptibility to Lipopolysaccharides]; more ... | CTD | PMID:22363816 |
| trans-resveratrol | multiple interactions | ISO | RGD:68534 | 6480464 | [resveratrol results in decreased activity of MTOR protein] inhibits the reaction [Tunicamycin results in increased expression of DDIT3 mRNA]; more ... | CTD | PMID:21321189 |
| trans-resveratrol | multiple interactions | ISO | RGD:68534 | 6480464 | resveratrol promotes the reaction [MTOR protein binds to DEPTOR protein] | CTD | PMID:20851890 |
| trans-resveratrol | multiple interactions | ISO | RGD:68534 | 6480464 | resveratrol inhibits the reaction [Glucose results in increased activity of MTOR protein] | CTD | PMID:19765649 |
| trans-resveratrol | multiple interactions | EXP | | 6480464 | [resveratrol results in increased activity of SIRT1 protein] which results in decreased activity of MTOR protein; more ... | CTD | PMID:20169165 |
| trans-resveratrol | decreases phosphorylation | EXP | | 6480464 | resveratrol results in decreased phosphorylation of MTOR protein | CTD | PMID:21168265 PMID:21179458 |
| trans-resveratrol | decreases expression | EXP | | 6480464 | resveratrol results in decreased expression of MTOR protein modified form | CTD | PMID:22234583 |
| trans-resveratrol | multiple interactions | EXP | | 6480464 | [resveratrol results in decreased activity of MTOR protein] which results in decreased expression of PKM mRNA; more ... | CTD | PMID:22574221 |
| trans-resveratrol | multiple interactions | EXP | | 6480464 | [resveratrol results in decreased activity of MTOR protein] which results in decreased expression of DDIT3 protein | CTD | PMID:21321189 |
| trans-resveratrol | decreases activity | EXP | | 6480464 | resveratrol results in decreased activity of MTOR protein | CTD | PMID:21321189 PMID:22574221 |
| trans-resveratrol | multiple interactions | EXP | | 6480464 | PTEN protein promotes the reaction [resveratrol results in decreased phosphorylation of MTOR protein] | CTD | PMID:21168265 |
| trans-resveratrol | multiple interactions | EXP | | 6480464 | Niacinamide inhibits the reaction [resveratrol results in decreased phosphorylation of MTOR protein]; more ... | CTD | PMID:19928762 |
| trans-resveratrol | increases phosphorylation | ISO | RGD:68534 | 6480464 | resveratrol results in increased phosphorylation of MTOR protein | CTD | PMID:22363816 |
| trans-resveratrol | decreases phosphorylation | ISO | RGD:68534 | 6480464 | resveratrol results in decreased phosphorylation of MTOR protein | CTD | PMID:20851890 |
| trans-resveratrol | multiple interactions | ISO | RGD:68534 | 6480464 | resveratrol inhibits the reaction [TNF protein results in increased phosphorylation of MTOR protein] | CTD | PMID:22069489 |
| trans-resveratrol | increases expression | EXP | | 6480464 | resveratrol results in increased expression of MTOR mRNA | CTD | PMID:12002526 |
| tributylstannane | decreases phosphorylation | ISO | RGD:68371 | 6480464 | tributyltin results in decreased phosphorylation of MTOR protein | CTD | PMID:20371977 |
| trichloroethene | increases expression | ISO | RGD:68534 | 6480464 | Trichloroethylene results in increased expression of MTOR mRNA | CTD | PMID:19448997 |
| trifluoperazine | multiple interactions | ISO | RGD:68534 | 6480464 | Trifluoperazine inhibits the reaction [Cadmium Chloride results in increased phosphorylation of MTOR protein] | CTD | PMID:21544200 |
| trifluoperazine | multiple interactions | ISO | RGD:68371 | 6480464 | Trifluoperazine inhibits the reaction [Cadmium Chloride results in increased phosphorylation of MTOR protein] | CTD | PMID:21544200 |
| trimellitic anhydride | increases expression | ISO | RGD:68534 | 6480464 | trimellitic anhydride results in increased expression of MTOR mRNA | CTD | PMID:19042947 |
| tunicamycin | multiple interactions | ISO | RGD:68534 | 6480464 | [resveratrol results in decreased activity of MTOR protein] inhibits the reaction [Tunicamycin results in increased expression of DDIT3 mRNA]; more ... | CTD | PMID:21321189 |
| vancomycin | increases expression | ISO | RGD:68534 | 6480464 | Vancomycin results in increased expression of MTOR mRNA | CTD | PMID:18930951 |
| wortmannin | multiple interactions | EXP | | 6480464 | wortmannin inhibits the reaction [Capsaicin results in increased phosphorylation of MTOR protein] | CTD | PMID:19139269 |
| zinc pyrithione | decreases expression | EXP | | 6480464 | zinc pyrithione results in decreased expression of MTOR protein | CTD | PMID:21557991 |